Trial Profile
A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Prior to Surgery in Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Adavosertib (Primary) ; Cisplatin; Docetaxel
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 11 Mar 2019 Status changed from active, no longer recruiting to completed.
- 09 Nov 2018 Planned primary completion date changed from 1 May 2018 to 12 Jun 2019.
- 13 Mar 2018 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research